Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 06-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 136,106 | 29,278 | 39,305 |
| Receivables | 71 | 56 | 12 |
| Other current assets | 6,894 | 9,497 | 12,345 |
| TOTAL | $143,071 | $38,831 | $51,662 |
| Non-Current Assets | |||
| PPE Net | 15,570 | N/A | 14,781 |
| Investments And Advances | 577 | 512 | 592 |
| Other Non-Current Assets | 24 | 80 | 183 |
| TOTAL | $16,171 | $592 | $15,556 |
| Total Assets | $153,103 | $49,291 | $62,950 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 8,117 | 9,765 | 8,702 |
| Other current liabilities | 13,632 | 9,108 | 7,366 |
| TOTAL | $21,751 | $18,873 | $16,069 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 50,856 | 54,856 | 49,018 |
| TOTAL | $50,856 | $54,856 | $49,018 |
| Total Liabilities | $72,607 | $73,729 | $65,087 |
| Shareholders' Equity | |||
| Common Shares | 1,180 | 751 | 753 |
| Retained earnings | -38,370 | -22,660 | -57,025 |
| Other shareholders' equity | -174,440 | -169,861 | -117,381 |
| TOTAL | $80,496 | $-24,438 | $-2,137 |
| Total Liabilities And Equity | $153,103 | $49,291 | $62,950 |